HB 1224 – WashingtonStatus: Enacted
Year Introduced: 2019
Year Enacted: 2019
CONCERNING PRESCRIPTION DRUG COST TRANSPARENCY. Requires health carriers, pharmacy benefit managers, pharmacy services administrative organizations, and drug manufacturers to report certain prescription drug pricing data to the Health Care Authority (HCA). Requires manufacturers to provide advance notice to the HCA before increasing the price of certain drugs. Requires the HCA to analyze the data and provide an annual report to the Legislature.
Return to Database Search
© 2018-2019 The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.